Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

Participants in the trial were symptomatic despite treatment with standard of care, intranasal corticosteroids (INCS ... chair of Rhinology & Endoscopic Sinus and Skull Base Surgery, and Allergy ...

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.

UAE residents always welcome the onset of cool winter months, but there are some who suffer from seasonal ailments like ...

Study participants were symptomatic even with standard of care treatment (intranasal corticosteroids ... vice chair of Rhinology & Endoscopic Sinus and Skull Base Surgery, and Allergy ...

Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

Getting a diagnosis of hidradenitis suppurativa (HS) can be overwhelming, especially if you’ve never heard of the condition ...

Participants in the trial were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]).1 Dr. Joseph Han, Vice Chair of Rhinology & Endoscopic Sinus and Skull Base ...

Participants in the trial were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]). 1 Dr. Joseph Han, Vice Chair of Rhinology & Endoscopic Sinus and Skull Base ...

The chronic sinus and nasal passage inflammation seen in CF patients ... managing the underlying conditions contributing to ...